Insights: Treating Addiction to Opioids in a Criminal Justice Setting: NIH Policy Brief

Roughly 65% of people in U.S. jails and prisons meet the criteria for a substance use disorder. Yet most never receive the care they need while incarcerated. This gap creates serious risks not only for individuals but also for families, communities, and public safety.

Incarceration can feel like a pause in life. But for people struggling with opioid addiction, it can also become a turning point. When evidence-based treatment is introduced during this time, it creates a path toward recovery that continues after release, often supported by sober living environments.

Why Medication Matters in Opioid Addiction Treatment

Medications for opioid use disorder are widely recognized as the most effective form of treatment. These include:

• Buprenorphine
• Methadone
• Extended-release naltrexone

These medications help stabilize brain chemistry and support long-term recovery. When provided during incarceration, they can change outcomes in meaningful ways.

Key benefits of medication-assisted treatment:

• Reduces opioid use and relapse rates
• Lowers the risk of fatal overdose
• Improves retention in treatment programs
• Decreases the transmission of infectious diseases like HIV and hepatitis C
• Reduces criminal activity linked to substance use
• Supports smoother reintegration into society

Medication works best when paired with behavioral counseling and recovery support. Detox alone, especially without follow-up care or sober living support, rarely leads to lasting sobriety.

Medication Improves Post-Release Outcomes

The period immediately after release is one of the most dangerous times for people with opioid use disorder. Tolerance drops during incarceration, making relapse far more likely to result in overdose.

Starting treatment inside correctional settings makes a measurable difference.

• Individuals who begin methadone or buprenorphine while incarcerated are far more likely to continue treatment after release
• Studies funded by the National Institute on Drug Abuse show reduced relapse rates among those receiving extended-release naltrexone
• Continuity of care increases engagement, with some programs reporting over 90% retention after release

On the other hand, forcing people to stop medication during incarceration can lead to:

• Increased withdrawal distress
• Higher relapse risk after release
• Lower willingness to seek treatment again

When treatment continues beyond incarceration and is paired with sober living housing, individuals have a stronger foundation for recovery.

Evidence-Based Treatment Saves Lives and Reduces Costs

Expanding access to medication-assisted treatment is not only effective, it is cost-efficient.

A California analysis found that providing methadone or buprenorphine saved more than $18,000 per person within six months compared to detox-only care. Programs that diverted individuals to treatment instead of incarceration saved the state millions in just one year.

The human impact is even more striking.

• People released from incarceration face an extremely high overdose risk in the first two weeks
• In Washington State, the risk of death from overdose was 129 times higher during this period
• Access to medication during and after incarceration reduced overdose deaths by up to 75%

These outcomes highlight the importance of connecting individuals to continued care, including outpatient services and sober living homes.

Treatment Access Remains Limited in U.S. Jails

Despite strong evidence, access to treatment in correctional settings is still limited.

• Only about 11% of incarcerated individuals who need addiction treatment receive it
• Methadone is often restricted, historically limited to specific populations such as pregnant individuals
• Buprenorphine access remains inconsistent across facilities
• Drug courts have not always allowed medication use, though policies are improving

Global health guidance supports broader access. Public health recommendations emphasize that correctional systems should offer medications for opioid use disorder as part of standard care.

Debunking Myths About Medication-Assisted Treatment

Misunderstandings about medication continue to limit access and acceptance.

Common myths and the facts:

• Myth: Medication replaces one addiction with another
• Fact: These medications do not produce a euphoric high when used as prescribed
• Myth: People should detox and stay drug-free without medication
• Fact: Medication reduces cravings and supports brain stability, improving recovery outcomes
• Myth: Diversion is widespread in correctional settings
• Fact: Reported diversion rates are relatively low and can be managed with proper supervision

Clear, accurate information helps reduce stigma and encourages more people to seek care, especially when transitioning into sober living environments.

Science-Based Innovations in Justice-Linked Treatment

Ongoing research continues to improve how treatment is delivered within the criminal justice system.

Current areas of focus include:

• Long-acting injectable medications that last weeks or months
• Improved HIV and infectious disease testing linked to treatment
• Programs designed for youth in the justice system to prevent long-term substance use

These efforts aim to create a stronger bridge between incarceration and long-term recovery, ensuring that individuals do not fall through gaps in care.

Connecting Treatment to Long-Term Recovery and Sober Living

Treatment during incarceration is only the beginning. Recovery continues after release, and the transition period requires structure, support, and accountability.

This is where sober living plays a critical role.

Benefits of sober living after incarceration:

• Provides a stable and substance-free environment
• Reinforces routines and daily accountability
• Encourages peer support and shared recovery goals
• Helps individuals rebuild independence gradually
• Reduces relapse risk during early recovery

Sober living homes act as a bridge between treatment and independent life. They give people the time and space to rebuild habits, reconnect with work and family, and stay engaged in recovery programs.

If you or someone you care about is leaving incarceration, exploring sober living options can be a strong next step. Tools like Sober House Directory can help identify homes that offer structure, safety, and community.

Vanderburgh Sober Living homes are designed to support this transition, offering recovery-focused environments where individuals can move forward with confidence.

Final Thoughts

Incarceration does not have to interrupt recovery. With the right treatment, it can become a starting point.

Expanding access to medication-assisted treatment inside correctional settings, and connecting individuals to sober living after release, creates better outcomes across the board. It reduces overdose deaths, lowers recidivism, and helps people rebuild their lives with stability and support.

Recovery is possible. The opportunity is already there. The focus now is making sure that opportunity reaches everyone who needs it.

References

1. Behind Bars II: Substance Abuse and America's Prison Population (2010) 
2. Spaulding AC et al. PLoS ONE (2009) 
3. Mattick RP et al. Cochrane Database Syst Rev. (2014) 
4. Mattick RP et al. Cochrane Database Syst Rev. (2009) 
5. Bentzley BS et al. J Subst Abuse Treat (2015) 
6. Kinlock TW et al. Drug Alcohol Dependence (2007) 
7. Zaller N et al. J Subst Abuse Treat. (2013) 
8. Gordon MS et al. Drug Alcohol Depend (2014) 
9. Lee JD et al. N Engl J Med. (2016) 
10. Maradiaga JA et al. J Subst Abuse Treat. (2016) 
11. Westerberg VS et al. J Substance Abuse Treat. (2016) 
12. Krebs E et al. Addiction (2017) 
13. Douglas Anglin M et al. Am J Public Health (2013) 
14. Binswanger IA et al. N Engl J Med. (2007) 
15. Degenhardt L et al. Addiction (2014) 
16. World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence (2009) 
17. Nunn A et al. Drug Alcohol Depend. (2009) 
18. Matusow H, et al. J Subst Abuse Treat. (2013) 
19. Fiscella K, et al. J Urban Health (2004) 
20. Magura S et al. Drug Alcohol Depend. (2009) 
21. Kinlock TW et al. J Offender Rehabil. (2010) 
22. Treating Opioid Addiction in Criminal Justice Settings